51 F
New York
Tuesday, April 20, 2021

MediciNova [NASDAQ: MNOV] Strikes Deal With BioComo And Mie University For SARS-CoV-2 Vaccine Development

Must read

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

MediciNova, Inc. [NASDAQ: MNOV] inked a deal to co-develop the SARS-CoV-2 vaccine with Mie University of Japan & BioComo. MediciNova will develop the COVID-19 vaccine using the human parainfluenza virus type 2 vector, BC-PIV.

BC-PIV is being developed by Mie University & BioComo. BC-PIV has been derived from hPVI2 and it is a non-communicable viral vector. It has the ability to pass on multiple foreign proteins to recipients. BC-PIV is also very safe as no other infectious virus is developed.

It has the ability to carry the large membrane proteins of viruses & signal transduction receptors protein on the surface of the virus. It is developed in a way that it not only display the gene but also exhibits foreign protein itself on the surface & inside the viral membrane.

The SARS-CoV-2 vaccine sample has been created to include the specific SARS-CoV-2 antigen protein in order to show maximum antigenicity. The firm has already got the right to use the BC-PIV for the development of the SARS-CoV-2 vaccine from Mie University & BioComo.

MediciNova, Inc. shares had tumbled 2.08% at $5.64 during the trading of Friday. It had a trading volume of rougly 49k and an average volume of 128.29k. If we look at its profitability, it has return on assets of -14.10%, return on equity of -14.80%.

MediciNova, Inc has recorded the current ratio of 34.60. Likewise, its quick ratio s 34.60. In the past 52-weeks of trading, this company’s stocks has changed between the 52-weeks low of $2.79 and a high of $9.95. It has moved up 102.15% from its 52-weeks low and moved down -43.33% from its 52-weeks high.

President and Chief Executive Officer of MediciNova, Inc, Yuichi Iwaki, M.D., Ph.D. said that the COVID-19 pandemic has spread all around and this is a great opportunity for the company to co-develop the vaccine with BioComo and Mie University.

BioComo had developed the vaccines for Ebola virus and RS virus using the BC-PIV technology. MediciNova is confident that this BC-PIV technology will also be successful in the development of the SARS-CoV-2 vaccine. Furthermore, it is very attractive that a BC-PIV SARS-CoV-2 vaccine can be made as an intranasal formulation.  

More articles

Latest article

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...

Aurora Mobile [NASDAQ: JG] Signs Partnership Agreement with Yivi

Aurora Mobile Limited revealed that it has inked a collaboration deal with Hangzhou Yivi Intelligent Technology Co., LTD. (Yivi). Yivi and Aurora both...

Total [NYSE: TOT] Join Forces with Siemens Energy to Reduce LNG Related Emissions

Total SE has joined forces with Siemens Energy to explore the solution for the reduction of CO2 emissions. The firms have inked a...

Kaixin [NASDAQ: KXIN] Signs Cooperation Agreement with Jingdong

Kaixin Auto Holdings declared Monday that it has inked a deal with Jingdong Century Trade Limited. The agreement is the collaboration agreement between...